|
CCNT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65456537359887E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.56350504659986E-11 |
| Normal-vs-Stage2 |
4.4232000000477E-06 |
| Normal-vs-Stage3 |
5.20770093714873E-11 |
| Normal-vs-Stage4 |
2.55999998977074E-10 |
| Stage1-vs-Stage2 |
8.414600E-01 |
| Stage1-vs-Stage3 |
9.863900E-02 |
| Stage1-vs-Stage4 |
1.118760E-01 |
| Stage2-vs-Stage3 |
2.605600E-01 |
| Stage2-vs-Stage4 |
2.306200E-01 |
| Stage3-vs-Stage4 |
8.342200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.74380559676047E-13 |
| Normal-vs-AfricanAmerican |
3.641800E-04 |
| Normal-vs-Asian |
6.51029996578956E-09 |
| Caucasian-vs-AfricanAmerican |
4.644200E-01 |
| Caucasian-vs-Asian |
4.640400E-01 |
| AfricanAmerican-vs-Asian |
2.347800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0550005313803E-11 |
| Normal-vs-Female |
1.24099619469575E-11 |
| Male-vs-Female |
2.032100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85250037532114E-10 |
| Normal-vs-Age(41-60Yrs) |
4.23909796154476E-11 |
| Normal-vs-Age(61-80Yrs) |
5.68534108680296E-12 |
| Normal-vs-Age(81-100Yrs) |
1.022330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.854200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.523820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.428400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.343400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.169200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.997400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.084150E-02 |
| Classical-VS-Follicular |
1.172370E-01 |
| Classical-VS-Other |
5.014000E-02 |
| Classical-VS-Normal |
2.79349876564083E-11 |
| Tall-VS-Follicular |
3.277800E-01 |
| Tall-VS-Other |
1.898770E-01 |
| Tall-VS-Normal |
1.85219950488147E-10 |
| Follicular-VS-Other |
3.718300E-02 |
| Follicular-VS-Normal |
7.03149982683726E-10 |
| Other-VS-Normal |
4.06459999990894E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.29269986013514E-12 |
| Normal-vs-N1 |
1.56159996045346E-09 |
| N0-vs-N1 |
3.336800E-01 |
|
|
